France· FR:61065315
ENTOCORT 3 mg, microgranules gastro-résistants en gélule
A medicinal product containing budésonide, registered in France by TILLOTTS PHARMA (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BUDÉSONIDE
- Manufacturer
- TILLOTTS PHARMA (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009341477151 flacon(s) polyéthylène de 45 gélule(s)EUR 42.66
- cip1334009341478831 flacon(s) polyéthylène de 90 gélule(s)EUR 84.91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Budésonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenBudenofalk 3 mg Enterokapsel, hårdDr Falk Pharma GmbH
- United KingdomBudenofalk 3mg gastro-resistant capsulesMawdsley-Brooks & Company Ltd
- United StatesBudesonideBryant Ranch Prepack
- IrelandBudenofalk 3 mg gastro-resistant capsulesDr. Falk Pharma GmbH
- NetherlandsBudenofalk, maagsapresistente capsules 3 mgDr. Falk Pharma Benelux B.V.
- FinlandBudenofalkDr. Falk Pharma GmbH
- SpainINTESTIFALK 3 mg CAPSULAS GASTRORRESISTENTESDr. Falk Pharma Gmbh
- CzechiaBUDENOFALKDr. Falk Pharma GmbH, Freiburg
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Belgium · Budenofalk, Budesonid Sandoz
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Germany · Aquacort, Budapp Nasal
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Poland · Bds N, Benodil
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f823fa5-29d7-4ceb-a728-e1aefa14757b GET /v1/drugs/8f823fa5-29d7-4ceb-a728-e1aefa14757b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61065315",
"date_amm": "1996-07-31",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BUDÉSONIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "microgranule gastro-résistant(e) en gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about budésonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.